China Ventilator Associated Pneumonia (VAP) Therapeutics Market Research Report 2018

February 2018 | 117 pages | ID: C0502933B5CEN
QYResearch

Abstracts

The global Ventilator Associated Pneumonia (VAP) Therapeutics market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Ventilator Associated Pneumonia (VAP) Therapeutics development status and future trend in China, focuses on top players in China, also splits Ventilator Associated Pneumonia (VAP) Therapeutics by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Achaogen Inc
• Adenium Biotech ApS
• Aridis Pharmaceuticals LLC
• AstraZeneca Plc
• Bayer AG
• Cardeas Pharma Corp
• Destiny Pharma Ltd
• Dong-A Socio Holdings Co Ltd
• Lakewood-Amedex Inc
• MedImmune LLC
• Meiji Seika Pharma Co Ltd
• Merck & Co Inc
• Motif Bio Plc
• Nabriva Therapeutics AG
• Polyphor Ltd
• Shionogi & Co Ltd
• Tetraphase Pharmaceuticals Inc
• The Medicines Company
• Theravance Biopharma Inc
• Wockhardt Ltd
• Zavante Therapeutics Inc

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (Units), revenue (Million USD), product price (K USD/Unit), market share and growth rate of each type, primarily split into

• Prevention
• Physiotherapy
• Immunity Therapy

On the basis of the end users/application, this report covers

• Hospitals
• Ambulatory Surgical Center
• Diagnostic Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Ventilator Associated Pneumonia (VAP) Therapeutics Market Research Report 2017

1 VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Ventilator Associated Pneumonia (VAP) Therapeutics
1.2 Classification of Ventilator Associated Pneumonia (VAP) Therapeutics by Product Category
  1.2.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Comparison by Type (2012-2022)
  1.2.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Market Share by Type in 2016
  1.2.3 Prevention
  1.2.4 Physiotherapy
  1.2.5 Immunity Therapy
1.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Market by Application/End Users
  1.3.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Center
  1.3.4 Diagnostic Centers
1.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Market by Region
  1.4.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2012-2022)
  1.4.3 East China Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2012-2022)
  1.4.4 Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2012-2022)
  1.4.5 Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2012-2022)
  1.4.6 North China Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2012-2022)
  1.4.7 Central China Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Ventilator Associated Pneumonia (VAP) Therapeutics (2012-2022)
  1.5.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2022)
  1.5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Average Price (K USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Competitive Situation and Trends
  2.4.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Concentration Rate
  2.4.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Ventilator Associated Pneumonia (VAP) Therapeutics Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS SALES AND REVENUE BY REGION (2012-2017)

3.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Market Share by Region (2012-2017)
3.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Price (K USD/Unit) by Regions (2012-2017)

4 CHINA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Price (K USD/Unit) by Type (2012-2017)
4.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (%) by Type (2012-2017)

5 CHINA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS SALES BY APPLICATION (2012-2017)

5.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Market Share by Application (2012-2017)
5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Achaogen Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Adenium Biotech ApS
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Aridis Pharmaceuticals LLC
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AstraZeneca Plc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bayer AG
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Cardeas Pharma Corp
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Destiny Pharma Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Dong-A Socio Holdings Co Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Lakewood-Amedex Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 MedImmune LLC
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Ventilator Associated Pneumonia (VAP) Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Meiji Seika Pharma Co Ltd
6.12 Merck & Co Inc
6.13 Motif Bio Plc
6.14 Nabriva Therapeutics AG
6.15 Polyphor Ltd
6.16 Shionogi & Co Ltd
6.17 Tetraphase Pharmaceuticals Inc
6.18 The Medicines Company
6.19 Theravance Biopharma Inc
6.20 Wockhardt Ltd
6.21 Zavante Therapeutics Inc

7 VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Ventilator Associated Pneumonia (VAP) Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ventilator Associated Pneumonia (VAP) Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Forecast by Type (2017-2022)
11.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Forecast by Application (2017-2022)
11.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Revenue (Million USD) Market Split by Product Type
Table Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) by Application (2016-2022)
Figure Product Picture of Ventilator Associated Pneumonia (VAP) Therapeutics
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Market Share by Types in 2016
Figure Prevention Product Picture
Figure Physiotherapy Product Picture
Figure Immunity Therapy Product Picture
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Ventilator Associated Pneumonia (VAP) Therapeutics by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Center Examples
Table Key Downstream Customer in Ambulatory Surgical Center
Figure Diagnostic Centers Examples
Table Key Downstream Customer in Diagnostic Centers
Figure South China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales of Key Players/Manufacturers (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Share (%) by Players/Manufacturers
Figure 2017 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Share (%) by Players/Manufacturers
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue by Players/Manufacturers (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) by Players/Manufacturers
Table China Market Ventilator Associated Pneumonia (VAP) Therapeutics Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Ventilator Associated Pneumonia (VAP) Therapeutics Average Price of Key Players/Manufacturers in 2016
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Share of Top 3 Players/Manufacturers
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Ventilator Associated Pneumonia (VAP) Therapeutics Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Ventilator Associated Pneumonia (VAP) Therapeutics Product Category
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) by Regions (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Share (%) by Regions (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Share (%) by Regions (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) by Regions in 2016
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) by Regions (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) by Regions (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) by Regions in 2016
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Price (K USD/Unit) by Regions (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) by Type (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Share (%) by Type (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Share (%) by Type (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) by Type in 2016
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Ventilator Associated Pneumonia (VAP) Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Ventilator Associated Pneumonia (VAP) Therapeutics by Type in 2016
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Price (K USD/Unit) by Types (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (%) by Type (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) by Applications (2012-2017)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) by Applications (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) by Application (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) by Application in 2016
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (%) by Application (2012-2017)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (%) by Application (2012-2017)
Table Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%)(2012-2017)
Figure MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share (%) in China (2012-2017)
Figure MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share (%) in China (2012-2017)
Table Meiji Seika Pharma Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Merck & Co Inc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Motif Bio Plc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Nabriva Therapeutics AG Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Polyphor Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Shionogi & Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Tetraphase Pharmaceuticals Inc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table The Medicines Company Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Theravance Biopharma Inc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Wockhardt Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Zavante Therapeutics Inc Ventilator Associated Pneumonia (VAP) Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ventilator Associated Pneumonia (VAP) Therapeutics
Figure Manufacturing Process Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics
Figure Ventilator Associated Pneumonia (VAP) Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Ventilator Associated Pneumonia (VAP) Therapeutics Major Players/Manufacturers in 2016
Table Major Buyers of Ventilator Associated Pneumonia (VAP) Therapeutics
Table Distributors/Traders List
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Price (K USD/Unit) Trend Forecast (2017-2022)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Forecast by Type (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Forecast by Type (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Market Share Forecast by Type in 2022
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Forecast by Application (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Market Share Forecast by Application in 2022
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) Forecast by Regions (2017-2022)
Table China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources